SCHEMBL6828757

SCHEMBL6828757

CCc1c(OC)cccc1C(=O)OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.50
MAPT P10636 2/20 0.50
TSHR P16473 2/20 0.50
HSD17B10 Q99714 2/20 0.50
MAPK1 P28482 1/20 0.50
CTSD P07339 1/20 0.49
ALDH1A1 P00352 2/20 0.47
KDM4E B2RXH2 1/20 0.47
SLC6A3 Q01959 1/20 0.46
LMNA P02545 2/20 0.46
HSP90AA1 P07900 1/20 0.46
HTT P42858 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
TAS1R3 Q7RTX0 1/20 0.46
TAS1R1 Q7RTX1 1/20 0.46
NPC1 O15118 2/20 0.45
KMT2A Q03164 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
POLB P06746 1/20 0.44
CFTR P13569 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22481057 0.87 LMNA (0.53) GAAMAPTTSHRHSD17B10ALDH1A1
SCHEMBL7867154 0.87 GAA (0.48) GAAMAPTTSHRHSD17B10MAPK1
SCHEMBL16672550 0.86 MAPT (0.48) GAAMAPTTSHRHSD17B10MAPK1
SCHEMBL30429212 0.85 GAA (0.49) GAAMAPTTSHRHSD17B10MAPK1
SCHEMBL668473 0.85 GAA (0.49) GAAMAPTTSHRHSD17B10MAPK1
SCHEMBL669102 0.85 GAA (0.53) GAAMAPTTSHRHSD17B10MAPK1
SCHEMBL9887730 0.85 GAA (0.49) GAAMAPTTSHRHSD17B10MAPK1
SCHEMBL17950859 0.84 SMN1; SMN2 (0.53) GAAMAPTMAPK1CTSDALDH1A1
SCHEMBL1987451 0.84 HTT (0.54) TSHRHSD17B10MAPK1CTSDALDH1A1
SCHEMBL28680548 0.84 ALDH1A1 (0.53) GAAMAPTTSHRHSD17B10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630414-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN Captor Therapeutics S.A. (PL) 2025-10-15 EP disclosed
WO-2024121256-A1 TARGETED PROTEIN DEGRADATION USING BIFUNCTIONAL COMPOUNDS THAT BIND UBIQUITIN LIGASE AND TARGET MCL-1 PROTEIN CAPTOR THERAPEUTICS S.A. (PL) 2024-06-13 WO disclosed
EP-2474532-A1 Heteroaryl sulfonamides and CCR2 ChemoCentryx, Inc. (US) 2012-07-11 EP disclosed
WO-2004073612-A2 ESTROGEN RECEPTOR MODULATORS MERCK & CO. INC. (US) 2004-09-02 WO disclosed